Drug intelligence / Profile preview

lavender + chamomile

Development stage
Unknown
Modality
Small Molecules
Administration
Oral, Topical, Inhalation
01

Overview

Lavender + chamomile refers to a combination of the two herbal ingredients—lavender (Lavandula spp.) and chamomile (Matricaria chamomilla or Chamaemelum nobile)—commonly used together in dietary supplements, teas, topical products (such as hand sanitizers), and aromatherapy blends. Both herbs are classified as nervines with calming effects on the nervous system. They are traditionally used for stress relief, relaxation support, sleep aid, digestive comfort, and mild anti-inflammatory benefits. In topical formulations like hand sanitizers or cosmetics labeled "lavender + chamomile," these ingredients primarily serve as fragrances or soothing agents rather than active pharmaceutical components[1][2][8]. The mechanism of action is mainly attributed to their essential oils' interaction with neurotransmitter systems involved in relaxation (e.g., GABAergic pathways) and their anti-inflammatory phytochemicals such as apigenin in chamomile and linalool in lavender[5][7]. These combinations are not FDA-approved drugs but are widely marketed as dietary supplements or cosmetic products.

Brand names
XtraCare Lavender ChamomileVitabath Hand Sanitizer Lavender ChamomileTraditional Medicinals Chamomile with Lavender Tea
Other names
chamomile and lavenderchamomile + lavenderlavender and chamomile
02

Targets

PGHS-1 (Prostaglandin G/H Synthase 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)GABRR (GABA-A receptor subunit rho)SERT (Sodium-dependent serotonin transporter)COXGABA-B (Gamma-aminobutyric acid receptor type B)

Beyond the preview

Go deeper on lavender + chamomile.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on lavender + chamomile.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call